SLC30A10

Chr 1

solute carrier family 30 member 10

Also known as: HMDPC, HMNDYT1, ZNT10, ZNT8, ZRC1, ZnT-10

This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]

GeneReviewsResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.25
Clinical SummarySLC30A10
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 149 VUS of 316 total submissions
📖
GeneReview available — SLC30A10
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.25LOEUF
pLI 0.980
Z-score 3.20
OE 0.00 (0.000.25)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.58Z-score
OE missense 0.73 (0.650.82)
197 obs / 269.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.00 (0.000.25)
00.351.4
Missense OE?0.73 (0.650.82)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 0 / 11.9Missense obs/exp: 197 / 269.8Syn Z: 0.13

This gene — mechanism propensity

DN
0.6452th %ile
GOF
0.6639th %ile
LOF
0.4825th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF64% of P/LP variants are LoF · LOEUF 0.25
GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

316 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic4
VUS149
Likely Benign105
Benign32
Conflicting10
7
Pathogenic
4
Likely Pathogenic
149
VUS
105
Likely Benign
32
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
2
1
0
7
Likely Pathogenic
3
1
0
0
4
VUS
3
123
22
1
149
Likely Benign
0
5
30
70
105
Benign
0
0
32
0
32
Conflicting
10
Total101318571307

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

32 pathogenic / likely-pathogenic (of 43) ClinVar copy-number / structural variants overlap SLC30A10 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC30A10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →